Publications by authors named "Yuichiro Ogawa"
Article Synopsis
- Enzalutamide is an oral medication that helps prolong survival in men with castration-resistant prostate cancer (CRPC) and was evaluated for its effectiveness and safety in a study of 73 patients.
- The study found that patients without prior docetaxel treatment had a better response to enzalutamide, with 61.4% achieving a significant reduction in PSA levels, compared to only 24.1% in those who had received docetaxel.
- Common side effects included fatigue, anorexia, and nausea, and some patients experienced a PSA flare, which can occur in those who respond to treatment.
Mucinous tubular and spindle cell carcinoma (MTSCC) is a distinct entity in the World Health Organization classification of kidney tumors since 2004. Herein, we report a case of a patient with MTSCC of the kidney. A 48-year-man visited our hospital with a chief complaint of occult blood in his urine, confirmed by urine occult blood reaction.
View Article and Find Full Text PDFWe report a case of vesical endometriosis that worsened during the early pregnancy period. A 37-year old woman had been under treatment for endometriosis (including vesical endometriosis) by a gynecologist during the past 10 years. She was treated for sterility 1 year ago, and became pregnant through in vitro fertilization.
View Article and Find Full Text PDFThe effect of imidafenacin for the treatment of overactive bladder (OAB), in female patients with urge and mixed urinary incontinence was examined. Prior to administration and at 1, 2, 3, 4, 6, 8, 10 and 12 weeks after administration, symptoms and quality of life were assessed using the overactive bladder symptom score (OABSS) and the international consultation on incontinence questionnaire-short form (ICIQ-SF), respectively. After administration, OABSS and ICIQ-SF scores were improved significantly when compared to baseline values.
View Article and Find Full Text PDF